{
    "nct_id": "NCT03038152",
    "official_title": "A Prospective, Open Label Study of the Use of Magseed® and Sentimag® to Localize Axillary Lymph Nodes With Biopsy-Proven Metastases in Breast Cancer Patients",
    "inclusion_criteria": "* Histologically confirmed cT0-4, N1 breast cancer\n* Axillary lymph node metastasis with pathologic confirmation by needle biopsy\n* Clip placed in the sampled axillary lymph node before completing chemotherapy\n* Received neoadjuvant chemotherapy prior to surgical resection\n* Scheduled for targeted axillary dissection (defined as selective localization and removal of the clipped node and sentinel lymph node dissection [SLND])\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-2\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Distant metastases\n* Inflammatory breast cancer\n* Prior surgical axillary procedure including SLND or axillary node excision\n* Prior history of breast cancer in the ipsilateral breast\n* History of lymphoma\n* The subject is known to be pregnant. Premenopausal patients under the age of 50 must have a pregnancy test performed as standard of care before the MagSeed is placed\n* Previous radiation to the breast or axilla\n* Pacemaker of other implantable device in the chest wall",
    "miscellaneous_criteria": ""
}